Summary
- Current Price
- As of today, CGTX price is $0.70, down -5.55% on
- Current Price All-Time High
- CGTX price is currently -94.94% below its historical high of $13.80 set on
- Market Cap
- CGTX current market cap is $66M, down -57.99% year-over-year
- Revenue
- CGTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CGTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cognition Therapeutics, Inc. |
| Ticker | NASDAQ: CGTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cogrx.com |
| Employees | 25 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.70 | ||
| Price, 1D Change | -5.55% | |
| $66M | ||
| - | ||
| - | ||
| 2.78 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.32 | ||
| EPS, 1Y Change | +62.25% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.32 | ||
| EPS Estimate | -$0.30 | N/A |
| EPS Est. Change | +8.09% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $0.70 | ||
| Price Target | $3.00 | - |
| Price Tgt. Change | +329.80% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.79 | -$0.86 | -8.92% | |
| -$0.39 | -$0.32 | +17.23% | |
| -$0.30 | N/A | +8.09% | |
| -$0.22 | N/A | +31.85% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -61.01% | ||
| -31.57% | ||
| -57.99% | ||
| +113.94% | ||
| 0.00% | ||
| 0.00% | ||
| +62.25% | ||
| +56.26% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.70 | ||
| $1.07 | ||
| $0.91 | ||
| $1.05 | ||
| $0.88 | ||
| -$0.06 | ||
| 2.78 | ||
| $0.06 | ||
| 32.52 | ||
| 70.56% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.32 | ||
| -$228.00K | ||
| - | ||
| -$47.80M | ||
| - | ||
| -$23.49M | ||
| - | ||
| -$47.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 3.45 | ||
| 3.45 | ||
| - | ||
| - | ||
| -5.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.01 | ||
| -0.89 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $34.27M | ||
| $37.00M | ||
| $48.39M | ||
| $47.99M | ||
| $14.12M | ||
| $13.92M | ||
| $638.00K | ||
| $443.00K | ||
| $1.12M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $23.49M | ||
| $47.57M | ||
| $228.00K | ||
| $0.00 | ||
| $228.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$24.59M | ||
| $9,000.00 | ||
| $36.57M | ||
| $0.00 | ||
| -$24.59M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CGTX
FAQ
- What is the ticker symbol for Cognition Therapeutics, Inc.?
- The ticker symbol for Cognition Therapeutics, Inc. is NASDAQ:CGTX
- Does Cognition Therapeutics, Inc. pay dividends?
- No, Cognition Therapeutics, Inc. does not pay dividends
- What sector is Cognition Therapeutics, Inc. in?
- Cognition Therapeutics, Inc. is in the Healthcare sector
- What industry is Cognition Therapeutics, Inc. in?
- Cognition Therapeutics, Inc. is in the Biotechnology industry
- What country is Cognition Therapeutics, Inc. based in?
- Cognition Therapeutics, Inc. is headquartered in United States
- When did Cognition Therapeutics, Inc. go public?
- Cognition Therapeutics, Inc. initial public offering (IPO) was on October 8, 2021
- Is Cognition Therapeutics, Inc. in the S&P 500?
- No, Cognition Therapeutics, Inc. is not included in the S&P 500 index
- Is Cognition Therapeutics, Inc. in the NASDAQ 100?
- No, Cognition Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Cognition Therapeutics, Inc. in the Dow Jones?
- No, Cognition Therapeutics, Inc. is not included in the Dow Jones index
- When was Cognition Therapeutics, Inc. last earnings report?
- Cognition Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
- When does Cognition Therapeutics, Inc. report earnings?
- The date for Cognition Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CGTX Official Website www.cogrx.com
- CGTX Profile on Yahoo Finance finance.yahoo.com/quote/CGTX
- CGTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cgtx